Vident Advisory, LLC

SEC CIK: 0001744347
Latest filing: Aug 12, 2026

SEC filings (opens in a new tab)

ACAD holding history

Acadia Pharmaceuticals Inc in every 13F filed by Vident Advisory, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ACAD overview All 13F holders of ACAD Full Q2 2026 holdings

Shares (Q3 2024): 0; Sold out in Q3 2024
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q4 2023

Holdings of ACAD by Vident Advisory, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2024	0	$0	0.0%	−14,179−100.0%	Sold out	Holders
Q2 2024	14,179	$230.4K	<0.1%	+14,179	New	Holders
Q1 2024	0	$0	0.0%	−7,279−100.0%	Sold out	Holders
Q4 2023	7,279	$227.9K	<0.1%	+7,279	New	Holders